Science. 2000 Jun 9;288(5472):1715b-7b. doi: 10.1126/science.288.5472.1715b.
On 31 May, the Cystic Fibrosis (CF) Foundation of Bethesda, Maryland, announced that it will invest at least $30 million in a small biotech firm, Aurora Biosciences of San Diego, to identify compounds that might prove useful in treating CF. This project, fueled initially by a donation of $20 million from the Bill and Melinda Gates Foundation, marks a new departure in the growing trend of patient groups taking charge of biomedical research.
5 月 31 日，马里兰州贝塞斯达的囊性纤维化基金会宣布，将向圣地亚哥的 Aurora Biosciences 这家小型生物技术公司投资至少 3000 万美元，以鉴定可能对囊性纤维化治疗有用的化合物。这个项目最初由比尔及梅林达·盖茨基金会捐赠 2000 万美元启动，标志着患者群体开始主导生物医学研究这一不断增长趋势的一个新起点。
